Huma

Отрасль

Защита растений, Экология и мониторинг, Удобрения и питание растений, Пищевые ингредиенты, Рекультивация, Вода

Темы

Сточные воды, водоочистка и биоремедиация

Роль

Производитель — “…culture, turf, ornamentals, manufacturing additives, and soil and wastewater bioremediation. Benefits claimed…”

Почему это биоэкономика

Huma — компания, принадлежащая сотрудникам: разрабатывает и производит гуминовые биостимуляторы, удобрения и средства биоремедиации.

Как найдена

Sound Agriculture; [Rubric] United States · biostimulants

Пока не указана поставщиком в решениях с доказательствами.

Дочерние компании: Mesa Verde Humates® · Gro-Power, Inc.

• 2023-05 or earlier Последний статус: Компания сменила название с Bio Huma Netics, Inc. на Huma, Inc. ↗ ↗ ↗
• 2026-08-24 Humacyte Confirms Plans for ATEV Supplemental BLA Filing
  Humacyte says it plans to file a supplemental Biologic License Application with the FDA in November 2026 to add dialysis access as the second approved indication for its acellular tissue engineered vessel (ATEV), based on positive Phase 3 results (including …
• 2026-08-19 Humacyte Publishes V007 Phase 3 Trial Results - HUMA
  Humacyte announces publication of one-year results from the V007 Phase 3 trial of its acellular tissue engineered vessel (ATEV) for hemodialysis AV access in The Lancet Digital Health, showing superiority of ATEV over autogenous fistula, especially for women …
• 2026-08-21 Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
  Kahn Swick & Foti, LLC announced it continues an investigation into Humacyte, Inc. (HUMA) executives and directors over potential fiduciary and securities-law breaches related to disclosures around Humacyte’s FDA BLA review and a Form 483 FDA inspection, with …
• 2026-08-23 Humaans Expands Into US Payroll As It Accelerates US Growth | Markets Insider
  Humaans is expanding into the US payroll market, launching Humaans Payroll to integrate payroll with its existing workforce data, automation, and Athena AI platform, and rolling out to US customers this fall. This signals a strategic push to serve US-based and …
• 2026-04-25 Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
  Kahn Swick & Foti, LLC has initiated an investigation into Humacyte, Inc.’s officers and directors, focusing on potential fiduciary breaches and misconduct in connection with the company’s FDA BLA review process and related disclosures, including a Form 483 at …
• 2026-08-24 Humacyte Plans Supplemental BLA for ATEV - HUMA | BioPharmaWatch
  Humacyte plans to file a supplemental BLA with the FDA in November 2026 to add dialysis access as a second approved indication for its acellular tissue engineered vessel (ATEV), building on the December 2024 approval for vascular trauma and supported by …

Владельцы и инвесторы 3

Похожие компании

Bio-Gro, Inc. · BioScientific, Inc. · Reforestation Technologies International · AgroLiquid · Corteva Biologicals · The Global Organics Group of Companies · The Espoma Company · CanGrow Crop Solutions Inc.